EU-Innovation Network Workplan 2023

Summary of opinion: Loxitab,meloxicam, 07/09/2023, Positive

Summary of opinion: Poulvac Procerta HVT-IBD,turkey herpes virus, strain FC-126, expressing infectious bursal disease virus VP2 protein, live, 07/09/2023, Positive

Summary of opinion: Oxmax,Hemoglobin betafumaril (bovine), 07/09/2023, Positive

Summary of opinion: Prevexxion RN+HVT,Marek’s disease virus, strain RN1250, live,Turkey herpesvirus, strain FC126, Live, 07/09/2023, Positive

Sertindole : List of nationally authorised medicinal products - PSUSA/00002695/202301

Human medicines European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), aripiprazole, Schizophrenia;Bipolar Disorder, Date of authorisation: 30/06/2015, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 13/05/2022, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Hypoparathyroidism, Date of authorisation: 24/04/2017, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Akynzeo, netupitant,palonosetron, Vomiting;Neoplasms;Nausea;Cancer, Date of authorisation: 27/05/2015, Revision: 16, Status: Authorised